Roluperidone

N/A

Report date: 2026/05/06 20:02:28
NME

Base Information

Drug NameRoluperidone
Drug Alias NameCYR-101MIN-101MT-210
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonistsSigma-2 receptor antagonists
TargetsSerotonin 2a (5-HT2a) receptorSigma-2 receptor
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBulgariaUnited StatesUkraine +[7
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaN/A
Originator CompaniesMinerva Neurosciences Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesCyrenaic Pharmaceuticals
Active IndicationsSchizophrenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipedia